Current role
Biotechnology · Healthcare
Board Member
2021-01-01–present
Ann Lee
Equibles does not estimate personal net worth.
Get an email with a short summary when Prime Medicine, Inc. publishes a filing, an earnings call transcript or a press release.
Get PRME alertsAbout Ann Lee
Ann Lee is recorded as Board Member at Coya Therapeutics, Inc. (COYA) since January 1, 2021. The newest filing on record that lists Ann Lee as Board Member at Coya Therapeutics, Inc. (COYA) is dated May 13, 2026. The proxy statement of Prime Medicine, Inc. reports total compensation of $1,550,116 for Ann Lee in fiscal 2025, including a base salary of $505,375. Disclosed compensation is on record for 4 fiscal years. Coya Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Prime Medicine, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Coya Therapeutics, Inc. includes Arun Swaminathan (CEO and Board Member), Dr. Arun Swaminathan (CEO), Howard Berman (Chairman) and 7 others.
Affiliation history
-
Current
2021-01-01–present
Last confirmed May 13, 2026
-
Prime Medicine, Inc. (PRME)
Proxy statement
CurrentStart not stated–present
Last confirmed April 23, 2026
Company network
Leadership on record at Coya Therapeutics, Inc.
- Arun Swaminathan CEO, Board Member
- Dr. Arun Swaminathan CEO
- Howard Berman Chairman
- David Snyder CFO, Board Member
- Anabella Villalobos Board Member
- Anabella Villalobos, Ph.D. Board Member
- Dieter Weinand Board Member
- Dov Goldstein Board Member
- Dov Goldstein, M.D., M.B.A. Board Member
- Fred Grossman Board Member
Leadership on record at Prime Medicine, Inc.
- Allan Reine CEO, Board Member
- Allan Reine, M.D. CEO, Board Member
- Jeffrey Marrazzo Chairman
- Svetlana Makhni CFO
- Svetlana N. Makhni CFO
- Jeff Marrazzo Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Prime Medicine, Inc. (PRME) | Chief Technical Officer | $505,375 | $1,550,116 |
| 2023 | Prime Medicine, Inc. (PRME) | Chief Technical Officer | $472,095 | $2,264,362 |
| 2022 | Prime Medicine, Inc. (PRME) | Chief Technical Officer | $453,937 | $947,279 |
| 2021 | Prime Medicine, Inc. (PRME) | Chief Technical Officer | $108,750 | $4,315,840 |
Recent activity
No call appearances or filed executive changes recorded yet.